Advance Cutting-Edge Research and Development with Next-Generation Cell Therapies, to Deliver Best-in-Class Products to Patients in Need

Cell therapies hold life-saving potential for patients, and the race is on to develop best-in-class, living, ‘thinking’ drugs. Relapse rates and barriers to solid tumor efficacy mean the cell therapy industry must innovate, now more than ever. 

The inaugural Multi-Functional Cell Therapies Summit gathers the avantgarde to discuss strategies to weaponize cell therapies with antigenic, engineered and combination approaches to create sophisticated, multi-functional systems.

"Multi-Functional Cell Therapies are a key step for the industry to overcome challenges in solid tumors. This summit is an important gathering of the minds to advance the next generation of life-saving therapies"

Francesco Marincola, CSO, Refuge Biotech

For more details about the program, speaker faculty or pricing and discounts, download the brochure.

Industry Leading Speakers Include

Jakob Dupont

EVP, Head of Global Research & Development

Atara Biotherapeutics

Juan Vera

CDO

Marker Therapeutics

Marc Van Dijk

CTO

AgenTus Therapeutics

Nadia Agopyan

VP Regulatory Affairs

Marker Therapeutics

Barbara Sennino

Director, Tumor Immunology

PACT Pharma

Richard Boyd

CSO

Cartherics Ltd.

Saul Priceman

Principal Investigator

City of Hope

Shon Green

Senior Director Translational R&D

Umoja Therapeutics

"An outstanding forum to gain valuable insights into new trends in cell therapy development"

Hanspeter Gerber, CSO, 3T Biosciences

“A truly outstanding summit that provides a unique opportunity for cross-functional information and experience sharing, thereby showing the way forward in CAR-TCR development”

Peggy Sotiropoulou, Head of R&D, Celyad Oncology

"I'm looking forward to speaking at the first Multi-Functional Cell Therapies Summit and hearing about the exciting work of other leading investigators in this rapidly-developing approach to disease management."

Lawrence Lamb, CSO & EVP, In8bio

“A truly professional forum to network and gain valuable insights into new trends in CAR-TCR development.”

Cheng Liu, CEO, Eureka Inc.

 

"Multi-Functional Cell Therapies are a key step for the industry to overcome challenges in solid tumors. This summit is an important gathering of the minds to advance the next generation of life-saving therapies"

Francesco Marincola, CSO, Refuge Biotech

"Gain great insights into new trends and mix with the avant-garde in cell immunotherapy development"

Sicco Popma, CEO, IO Bio Science

Proud to Partner With

Expertise Partners:

Exhibition Partner:

Other Events in the CAR-TCR Series

August 30 - September 2, 2021

October, 2021

November, 2021

February, 2022